PolyPid and Azurity Pharmaceuticals are partnering to commercialize D-PLEX 100, preventing surgical site infections (SSIs), ...

Forge Biologics, part of Ajinomoto Bio-Pharma Services, is partnering with Restore Vision on a gene therapy for retinitis ...

Wheeler Bio, a biologics-focused CDMO, is appointing Rajesh Beri, PhD, as its new Chief Development Officer. Beri’s expertise ...

ACG has appointed Lalit Kasliwal as Group Chief Financial Officer (CFO), where he will lead ACG’s global finance function, ...

Xmoor Pharma and Evox Therapeutics have completed a technology transfer program for Evox's exosome-enabled gene editing ...

Samsung Biologics has launched an all-cash public tender offer to acquire 100% of the fully diluted share capital of ...

Natoli Engineering Company Inc. has acquired Scheu & Kniss, a company with 100+ of experience providing tablet press ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has entered a multi-target strategic ...

As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

OXB has signed an agreement with Plowshare Therapies, a biotechnology company developing gene therapies for rare genetic ...

Bora Pharmaceuticals has completed its acquisition of MacroGenics, Inc.’s GMP manufacturing operations, including its biologics drug substance facility in Rockville, MD and an associated warehousing ...